Dormancy in breast cancer

E Dalla, A Sreekumar… - Cold Spring …, 2023 - perspectivesinmedicine.cshlp.org
The pattern of delayed recurrence in a subset of breast cancer patients has long been
explained by a model that incorporates a variable period of cellular or tumor mass dormancy …

Lysosomes at the crossroads of cell metabolism, cell cycle, and stemness

A Nowosad, A Besson - International Journal of Molecular Sciences, 2022 - mdpi.com
Initially described as lytic bodies due to their degradative and recycling functions, lysosomes
play a critical role in metabolic adaptation to nutrient availability. More recently, the …

mTOR pathway occupies a central role in the emergence of latent cancer cells

KV Aleksandrova, ML Vorobev, II Suvorova - Cell Death & Disease, 2024 - nature.com
The current focus in oncology research is the translational control of cancer cells as a major
mechanism of cellular plasticity. Recent evidence has prompted a reevaluation of the role of …

Outlook and opportunities for engineered environments of breast cancer dormancy

NR Richbourg, N Irakoze, H Kim, SR Peyton - Science Advances, 2024 - science.org
Dormant, disseminated breast cancer cells resist treatment and may relapse into malignant
metastases after decades of quiescence. Identifying how and why these dormant breast …

Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis

M Xu, F Ling, J Li, Y Chen, S Li, Y Cheng… - Frontiers in …, 2023 - frontiersin.org
Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders of the
gastrointestinal tract, mainly including Crohn's disease and ulcerative colitis …

Erythropoietin-producing hepatocellular receptor B6 is highly expressed in non-functioning pituitary neuroendocrine tumors and its expression correlates with tumor …

H Rubinfeld, ZR Cohen, U Bendavid… - Molecular biology …, 2024 - Springer
Background Erythropoietin-producing hepatocellular (EPH) receptors are the largest known
family of receptor tyrosine kinases characterized in humans. These proteins are involved in …

Cancer treatments as paradoxical catalysts of tumor awakening in the lung

E Nicolas, B Kosmider, E Cukierman… - Cancer and Metastasis …, 2024 - Springer
Much of the fatality of tumors is linked to the growth of metastases, which can emerge
months to years after apparently successful treatment of primary tumors. Metastases arise …

A new glance at autophagolysosomal-dependent or-independent function of transcriptional factor EB in human cancer

T Wang, Y Qin, Z Ye, D Jing, G Fan, M Liu… - Acta Pharmacologica …, 2023 - nature.com
Autophagy-lysosome system plays a variety of roles in human cancers. In addition to being
implicated in metabolism, it is also involved in tumor immunity, remodeling the tumor …

Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma

R Zhang, X Yang, X Shi, E Xing, L Wang, C Hao… - Leukemia Research, 2024 - Elsevier
Objective To explore the involvement of TFEB-mediated autophagy-lysosomal mechanisms
in multiple myeloma (MM) during bortezomib treatment. Methods MM cells were exposed to …

Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion

LY Liang, ND Geoghegan, M Mlodzianoski… - Communications …, 2024 - nature.com
EphB6 is an understudied ephrin receptor tyrosine pseudokinase that is downregulated in
multiple types of metastatic cancers. Unlike its kinase-active counterparts which …